The Food and Drug Administration on Jan. 31, 2020 approved Palforzia, Aimmune Therapeutics’ oral immunotherapy (OIT) treatment for peanut allergy… Read more »
Tag: Jayson Dallas
NEJM Publishes Positive Study Data on OIT Biologic for Peanut Allergy
The positive results of a pivotal Phase 3 study of a peanut biologic oral immunotherapy known as AR101 were published… Read more »